Indaptus Therapeutics, Inc. 8-K

What Happened

• Indaptus Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2026 in a press release dated May 15, 2026. The company filed a Current Report on Form 8-K (Item 2.02) to furnish that press release and provided business updates and forward‑looking statements in the release.

Key Details

• Date filed: May 15, 2026; quarter covered: ended March 31, 2026.
• The press release is furnished as Exhibit 99.1 to the Form 8-K.
• The press release includes business updates and forward‑looking statements; the company states the material is furnished (not “filed”) under Section 18 of the Exchange Act and is not incorporated by reference into other filings except where expressly stated.
• The filing also includes the Inline XBRL cover page (Exhibit 104).

Why It Matters

• This 8-K signals that Indaptus has released its latest quarterly earnings and operational update; investors should review the press release (Exhibit 99.1) for revenue, earnings, cash position, and any guidance or milestones that affect valuation.
• The company’s note that the release contains forward‑looking statements is a reminder to weigh those items accordingly and consult the full SEC filings for audited or detailed financial disclosures.